Nearly 35,000 Bottles of Nexium Recalled

AstraZeneca has launched a voluntary Class II recall of esomeprazole magnesium (Nexium) delayed-release capsules, 20 mg, due to the presence of foreign tablets.

The discovery of the atypical antipsychotic quetiapine fumarate (Seroquel) in an unopened bottle by a retail pharmacist prompted the recall. In July 2014, a study found that quetiapine fumarate was among the top ten psych drugs that led to emergency department visits.

The impacted products, totaling 34,524 bottles, is lot #FC0064, with an expiration date of May 2017.

The nationwide recall launched June 10.

--Stephanie Vaccaro

Reference:

1. U.S. Food and Drug Administration. Enforcement Report – Week of June 24, 2015. www.fda.gov. 2015 Jun 24.